ARTICLE | Company News
Millennium, ProBioGen deal
November 8, 2004 8:00 AM UTC
ProBioGen will use its Position Mediated Expression Enhancement system to develop cell lines for MLNM. The cell lines will produce antibodies for an undisclosed indication for preclinical trials at ML...